DE602004018985D1 - Epsilon-Polylysin gegen Halitose - Google Patents

Epsilon-Polylysin gegen Halitose

Info

Publication number
DE602004018985D1
DE602004018985D1 DE602004018985T DE602004018985T DE602004018985D1 DE 602004018985 D1 DE602004018985 D1 DE 602004018985D1 DE 602004018985 T DE602004018985 T DE 602004018985T DE 602004018985 T DE602004018985 T DE 602004018985T DE 602004018985 D1 DE602004018985 D1 DE 602004018985D1
Authority
DE
Germany
Prior art keywords
phosvitin
conjugated
casein phosphopeptide
partially
bisphosphonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004018985T
Other languages
English (en)
Inventor
Lucas Huybrechts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE602004018985D1 publication Critical patent/DE602004018985D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602004018985T 2004-01-19 2004-11-29 Epsilon-Polylysin gegen Halitose Expired - Fee Related DE602004018985D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE2004/0028A BE1015863A6 (nl) 2004-01-19 2004-01-19 Anticariogene proteinen & peptiden & sacchariden.
PCT/EP2004/013549 WO2005068645A2 (en) 2004-01-19 2004-11-29 Anticariogenic proteins & peptides & saccharides

Publications (1)

Publication Number Publication Date
DE602004018985D1 true DE602004018985D1 (de) 2009-02-26

Family

ID=34754164

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004018985T Expired - Fee Related DE602004018985D1 (de) 2004-01-19 2004-11-29 Epsilon-Polylysin gegen Halitose

Country Status (13)

Country Link
US (1) US20080226565A1 (de)
EP (1) EP1709069B1 (de)
JP (1) JP2007523891A (de)
CN (1) CN1922203A (de)
AT (1) ATE419828T1 (de)
BE (1) BE1015863A6 (de)
BR (1) BRPI0418420A (de)
CA (1) CA2553613A1 (de)
DE (1) DE602004018985D1 (de)
DK (1) DK1709069T3 (de)
ES (1) ES2320001T3 (de)
RU (1) RU2006129942A (de)
WO (1) WO2005068645A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702021D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
JP2009143874A (ja) * 2007-12-17 2009-07-02 Chisso Corp オーラルケア製品
JP2010160863A (ja) * 2009-01-09 2010-07-22 Hitachi Ltd 光ディスク装置及び多層式ディスク
CN101838467B (zh) * 2010-05-21 2013-05-29 南京农业大学 一种新型壳聚糖纳米颗粒及其制备方法
DE102011077067A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem odermehreren aromatischen Aldehyden
SG11201402057VA (en) 2011-12-15 2014-06-27 Colgate Palmolive Co Oral care compositions
US9724434B2 (en) 2012-03-13 2017-08-08 National University Corporation Okayama University Lysine oligomer derivative and cartilage tissue marker made thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
CN103932914B (zh) * 2013-09-03 2016-06-08 浙江康德药业集团股份有限公司 壳聚糖漱口液及其制备方法
KR101664444B1 (ko) 2013-12-13 2016-10-12 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 생분해성 의료용 접착제 또는 실란트 조성물
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
CN104248775B (zh) * 2014-09-22 2015-11-25 片仔癀（上海）生物科技研发有限公司 一种羟基磷灰石-壳聚糖复合凝胶及其制备工艺与用途
CN106446599A (zh) * 2015-08-11 2017-02-22 中国科学院青岛生物能源与过程研究所 一种筛选婴幼儿龋病的口腔致病性生物标记物的方法
CN105767419A (zh) * 2016-04-06 2016-07-20 俞祖勋 一种防龋齿糖果的制造方法
EP3597175A4 (de) * 2017-03-16 2020-12-16 Ezaki Glico Co., Ltd. Orale zusammensetzung zur förderung der zahnremineralisierung
CN107233228A (zh) * 2017-07-20 2017-10-10 杭州坦珮信息技术有限公司 一种防口臭和龋齿牙膏的制造方法
JP7198453B2 (ja) * 2019-01-30 2023-01-04 国立研究開発法人産業技術総合研究所 リグニンスルホン酸とε－ポリリジンを成分とするイオン複合材料

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
JP3114359B2 (ja) * 1992-05-14 2000-12-04 チッソ株式会社 抗う蝕および抗歯周病剤
US5587147A (en) * 1994-06-30 1996-12-24 Church & Dwight Co., Inc. Aqueous zinc-polyamide complex solution
AUPR517701A0 (en) * 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
WO2002103004A1 (en) * 2001-06-15 2002-12-27 The Children's Hospital Of Philadelphia Surface modification for improving biocompatibility
JP3862013B2 (ja) * 2002-09-13 2006-12-27 ライオン株式会社 口腔用組成物

Also Published As

Publication number Publication date
WO2005068645A2 (en) 2005-07-28
EP1709069A2 (de) 2006-10-11
CN1922203A (zh) 2007-02-28
JP2007523891A (ja) 2007-08-23
BE1015863A6 (nl) 2005-10-04
RU2006129942A (ru) 2008-02-27
WO2005068645B1 (en) 2005-12-08
DK1709069T3 (da) 2009-05-11
US20080226565A1 (en) 2008-09-18
BRPI0418420A (pt) 2007-05-15
ATE419828T1 (de) 2009-01-15
EP1709069B1 (de) 2009-01-07
CA2553613A1 (en) 2005-07-28
WO2005068645A3 (en) 2005-11-10
ES2320001T3 (es) 2009-05-18

Similar Documents

Publication Publication Date Title
DE602004018985D1 (de) Epsilon-Polylysin gegen Halitose
JP4629046B2 (ja) 反復配列タンパク質ポリマー活性剤結合体、方法および使用
EP3533461A3 (de) Von prame abstammende peptide und immunogene zusammensetzungen damit
BRPI0607097B8 (pt) uso de um peptídeo imunogênico para a fabricação de um medicamento para o tratamento, prevenção ou redução de infecção por papilomavírus
WO2007146269A3 (en) Peptide fragments for inducing synthesis of extracellular matrix proteins
DE60204714D1 (de) Pharmakologische nahrungszusammensetzung zur nahrungsergängzung und nährwertverbesserung
MX336118B (es) Expresion hibrida y en tandem de proteinas de neisseria.
WO2003093314A3 (en) Connective tissue stimulating peptides
BRPI0511421A (pt) composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo
BRPI0714336A2 (pt) utilizaÇço de um hidrolisado de proteÍnas de arroz como princÍpio ativo pigmentante.
WO2007048086A3 (en) Canine influenza virus and related compositions and methods of use
NO20091441L (no) Rekonstituerte surfaktanter med forbedrede egenskaper
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
ATE430165T1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
ATE422356T1 (de) Pharmazeutische zubereitungen
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
BR0308860A (pt) Fator viii modificado
BR0316493A (pt) ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres
ATE364999T1 (de) Modifizierte lupinproteine zur herstellung einer wasser-dispergierbaren produktform fettlöslicher stoffe
BRPI0408946A (pt) material biologicamente ativo conjugado com polìmero biocompatìvel com complexo 1:1, seu processo de preparação e composição farmacêutica compreendendo o mesmo
WO2009073909A8 (de) Zyklisches, cystein-freies protein
ATE362756T1 (de) Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
HUP0301396A2 (hu) Integrin inhibitor hatású peptid- és peptidutánzó konjugátumok, azokat tartalmazó implantátumok és alkalmazásuk

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee